From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer
- 3 May 2012
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 227 (3), 286-297
- https://doi.org/10.1002/path.4047
Abstract
The current paradigm of cancer care relies on predictive nomograms which integrate detailed histopathology with clinical data. However, when predictions fail, the consequences for patients are often catastrophic, especially in prostate cancer where nomograms influence the decision to therapeutically intervene. We hypothesized that the high dimensional data afforded by massively parallel sequencing (MPS) is not only capable of providing biological insights, but may aid molecular pathology of prostate tumours. We assembled a cohort of six patients with high‐risk disease, and performed deep RNA and shallow DNA sequencing in primary tumours and matched metastases where available. Our analysis identified copy number abnormalities, accurately profiled gene expression levels, and detected both differential splicing and expressed fusion genes. We revealed occult and potentially dormant metastases, unambiguously supporting the patients' clinical history, and implicated the REST transcriptional complex in the development of neuroendocrine prostate cancer, validating this finding in a large independent cohort. We massively expand on the number of novel fusion genes described in prostate cancer; provide fresh evidence for the growing link between fusion gene aetiology and gene expression profiles; and show the utility of fusion genes for molecular pathology. Finally, we identified chromothripsis in a patient with chronic prostatitis. Our results provide a strong foundation for further development of MPS‐based molecular pathology. Copyright © 2012 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.This publication has 66 references indexed in Scilit:
- Chromothripsis and Human Disease: Piecing Together the Shattering ProcessCell, 2012
- The genomic complexity of primary human prostate cancerNature, 2011
- Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer DevelopmentCell, 2011
- TMPRSS2–ERG gene fusion is associated with low Gleason scores and not with high-grade morphological featuresLaboratory Investigation, 2010
- Integrative Genomic Profiling of Human Prostate CancerCancer Cell, 2010
- Snail transcription factor regulates neuroendocrine differentiation in LNCaP prostate cancer cellsThe Prostate, 2010
- Nuclear Receptor-Induced Chromosomal Proximity and DNA Breaks Underlie Specific Translocations in CancerCell, 2009
- An integrative approach to reveal driver gene fusions from paired-end sequencing data in cancerNature Biotechnology, 2009
- Syndecan-2 overexpression regulates adhesion and migration through cooperation with integrin α2Biochemical and Biophysical Research Communications, 2009
- GenePattern 2.0Nature Genetics, 2006